Specialty:
“Dr. Alan So graduated with a medical degree from the University of Alberta. He completed his residency at Dalhousie University. Dr. Alan So completed his uro-oncology fellowship at Vancouver Prostate Centre/the University of British Columbia. During his post-doctoral fellowship, he published more than 10 peer-reviewed papers. Dr. So’s current research focuses on the study of the development of novel therapeutics for bladder cancer and the determination of the functional role of GLI1/2 in the progression of prostate cancer to its lethal stage of androgen independence. He has characterized the functional role of different survival genes (including clusterin and Hsp27) in other tumour models (prostate, breast, lung, and bladder) in cancer progression. Dr. Alan So is a member of the National Cancer Institute of Canada GU Clinical Trials Group and the Canadian Uro-Oncology Group.
Read more
2025 Update: He is a fellow of the Royal College of Surgeons of Canada. Dr. Alan So is a recipient of many awards, including the Vancouver General Hospital Foundation’s “In It For Life” Clinician Scientist Award, an ASCO “Young Scientist Award”, and a prestigious Michael Smith Foundation Post-Doctoral Fellowship Award. He leads the clinical trials unit at the Vancouver Prostate Cancer Centre and is the Chair of the Urology Surgical Tumour Group at the BC Cancer Agency.”
